Luo found that quercetin, the active component of licorice, has a strong docking ability with IL-6, suggesting that licorice may primarily reduce IL-6 levels in response to COVID-19 inflammatory outbreaks, which represents a prospective therapeutic strategy for moderate COVID-19 (Luo et al., 2022). Here, IL6 is linked to COVID-19.